ArticleTherapeutic advances in medical oncology2026

Low-level HBV viremia independently predicts poor outcomes in patients with intermediate-to-advanced HBV-related hepatocellular carcinoma receiving systemic therapy: a multicenter retrospective study.

Jin Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.